USEUCNOTHERClinicalTrials.gov【Trial record】
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2RecruitingSource updated: Oct 1, 2026
Cancer types
Pancreatic Cancer
Incl. pancreatic ductal adenocarcinoma. 88 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 88 of 88
Highlight terms:
Build a discussion list0 selected
Select the public official records you want to take to your appointment, then generate a list. Nothing is ranked or recommended — the list only reproduces titles and links.
Not signed in — up to 5 records per list. Sign in for higher free limits, or see Pro for more exports.
USEUCNOTHERClinicalTrials.gov【Trial record】
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Not applicableRecruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RecruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
Not applicableActive, not recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】
Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
Not applicableRecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
Phase 1Active, not recruitingSource updated: Sep 30, 2026
USEUClinicalTrials.gov【Trial record】
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
Phase 1/2Active, not recruitingSource updated: Sep 30, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Phase 2RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Cancer in Inherited Bone Marrow Failure Syndromes
RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
Phase 2RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Improving Surgeon Performance Measures for Robot-Assisted Surgery
Enrolling by invitationSource updated: Sep 30, 2026
USEUClinicalTrials.gov【Trial record】
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Phase 3Active, not recruitingSource updated: Sep 30, 2026
OTHERClinicalTrials.gov【Trial record】
Pancreatic Endoscopic Ultrasound-guided RadioFrequency for Inoperable Carcinoma Treatment
Not applicableNot yet recruitingSource updated: Sep 30, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Phase 3RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Phase 1RecruitingSource updated: Sep 29, 2026
USEUOTHERClinicalTrials.gov【Trial record】
A Study of PHN-012 in Patients With Advanced Solid Tumors
Phase 1RecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
Phase 1/2Active, not recruitingSource updated: Sep 29, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Phase 1RecruitingSource updated: Sep 29, 2026
EUClinicalTrials.gov【Trial record】
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
Phase 1/2Active, not recruitingSource updated: Sep 29, 2026
EUClinicalTrials.gov【Trial record】
Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients
Not applicableRecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma
RecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
Phase 1/2Active, not recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Phase 1/2RecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Phase 2RecruitingSource updated: Sep 29, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Phase 3Active, not recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
Phase 2Active, not recruitingSource updated: Sep 29, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/3RecruitingSource updated: Sep 29, 2026
USEUClinicalTrials.gov【Trial record】
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Phase 3RecruitingSource updated: Sep 28, 2026
USClinicalTrials.gov【Trial record】
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1RecruitingSource updated: Sep 28, 2026
USOTHERClinicalTrials.gov【Trial record】
Pancreatic Cancer Detection Consortium
RecruitingSource updated: Sep 28, 2026
USClinicalTrials.gov【Trial record】
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Phase 1/2RecruitingSource updated: Sep 28, 2026
USEUClinicalTrials.gov【Trial record】
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Phase 3RecruitingSource updated: Sep 28, 2026
EUClinicalTrials.gov【Trial record】
Surveillance of Pancreatic Health After Diabetes Diagnosis
Not applicableRecruitingSource updated: Sep 28, 2026
OTHERClinicalTrials.gov【Trial record】
Evaluation of XYA02 in Patients With Advanced Solid Tumors
Phase 1/2RecruitingSource updated: Sep 25, 2026
USClinicalTrials.gov【Trial record】
A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma
Phase 1Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Phase 3RecruitingSource updated: Aug 14, 2026
CNClinicalTrials.gov【Trial record】
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
Phase 3RecruitingSource updated: Aug 14, 2026
OTHERClinicalTrials.gov【Trial record】
Targeting Pathogenic Myelopoiesis in Pancreatic Cancer
Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC
Phase 2Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 2RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Phase 1/2RecruitingSource updated: Aug 13, 2026
OTHERClinicalTrials.gov【Trial record】
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancreatitis
Not yet recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Diagnosing and Treating Low Blood Sugar Levels
RecruitingSource updated: Aug 13, 2026
OTHERClinicalTrials.gov【Trial record】
EUS-DFI in Solid Pancreatic Lesions
Not yet recruitingSource updated: Aug 13, 2026
CNClinicalTrials.gov【Trial record】
Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs
RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Phase 1/2RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Phase 2RecruitingSource updated: Aug 12, 2026
CNClinicalTrials.gov【Trial record】
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
Phase 2RecruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
Phase 2Active, not recruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Phase 1/2RecruitingSource updated: Aug 12, 2026
USClinicalTrials.gov【Trial record】
Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer
Phase 3Active, not recruitingSource updated: Aug 12, 2026
EUClinicalTrials.gov【Trial record】
ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
Not applicableRecruitingSource updated: Aug 12, 2026
OTHERClinicalTrials.gov【Trial record】
TT-702 in Patients With Advanced Solid Tumours.
Phase 1/2RecruitingSource updated: Aug 12, 2026
EUClinicalTrials.gov【Trial record】
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Phase 1/2RecruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
Phase 2Active, not recruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Phase 2RecruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
Phase 2Active, not recruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
Phase 1RecruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Phase 1RecruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
Pilot Study of Pancreatic Cancer Screening
Active, not recruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Phase 1/2RecruitingSource updated: Aug 10, 2026
CNCDE【Guideline / public regulatory information】
CDE 临床试验默示许可 — clinical trial implied licence notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 优先审评公示 — priority review listings
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 受理品种信息 — applications accepted for review
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 指导原则 — published technical guidance documents
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 突破性治疗公示 — breakthrough therapy designation notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 附条件批准品种 — conditionally approved products list
Index verified: Aug 16, 2026
CNChiCTR【Guideline / public regulatory information】
ChiCTR — Chinese Clinical Trial Registry, public search
Index verified: Aug 16, 2026
EUCTIS【Guideline / public regulatory information】
CTIS public register — search clinical trials authorised in the EU/EEA
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — CHMP meeting highlights and opinions on new medicines
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — searchable database of authorised medicines in the EU
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — gastrointestinal cancers
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — public index by tumour type
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — supportive and palliative care section
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — expanded access (compassionate use) information for patients
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — oncology (cancer) / hematologic malignancies approval notifications
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — ongoing accelerated approvals for oncology indications
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — palliative care category listing
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — public index by cancer type (free registration)
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines for Patients — plain-language versions
Index verified: Aug 16, 2026
CNNMPA【Guideline / public regulatory information】
NMPA 药品 — national drug approval announcements
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Index verified: Aug 16, 2026